News By/Courtesy: Nikshetaa Jain | 21 May 2020 12:54pm IST

HIGHLIGHTS

  • Collaboration in the field of diagnostics and therapeutics of the disease
  • First collaboration between Indian and US pharmaceutical companies
  • Working together on vaccine research and testing

India and the US have been working together to combat the deadly virus, COVID 19. According to Taranjit Singh, the Indian Ambassador in the US, close collaboration in the area of diagnostics and therapeutics of the disease is underway. He said that India and the United States have a productive partnership in the healthcare sector. Under the bilateral collaboration in the healthcare sector, the National Institute of Allergy and Infectious Disease in the US shared critical reagents with the Translational Health Science Technology Institute in Gurgaon. Besides, Indian origin American companies are in contact with the Indian Council of Medical Research to enhance the abilities of COVID 19 testing in India. Collaboration in the sector of coronavirus was discussed when Donald Trump, the US President, visited India in February.

The Serum Institute of India, a Pune-based company, has collaborated with Codagenix Inc, a New York-based company, to develop a vaccine against COVID 19. This is the first collaboration between Indian and US pharmaceutical companies to develop a vaccine for coronavirus. On 7th April, the two pharma companies issued a press release stating that they aim to rapidly co-develop a live-attenuated vaccine (LAV) against the novel coronavirus. LAVs are derived from pathogens that have been weakened due to laboratory conditions. Since they are weak, they cause no or mild disease.

On 16th May, Donald Trump tweeted that America would donate ventilators to India. The US government has planned to donate 200 ventilators to India. The first batch of 50 ventilators is soon expected in the country. In his tweet, Trump stated that both the countries would beat the invisible enemy together. The director of the United States Agency for International Development (USAID) said that the ventilators were a donation to India. She said that they re working closely with the Ministry of Health and Family Welfare, the Indian Red Cross Society and any other relevant stakeholders to assist in the transportation of these donated ventilators. She said that USAID had announced USD 5.9 million in funding to combat COVID 19 in India.

On 19th May, India and the US have planned to work together on vaccine research and testing for COVID 19. In Delhi, the US Embassy Health and Human Services said that US and Indian scientists have been collaborating for the development of safe, cost-effective vaccines against t a range of infectious diseases. Partners under the Vaccine Action Programme are planning to work on the development and testing of vaccines. The VAP is a thirty-three-year-old collaboration between the US National Institute of Health, the Indian Department of Biotechnology and the Indian Council of Medical Research along with other partners.

Section Editor: Pushpit Singh | 21 May 2020 18:41pm IST


Tags : #COVID 19, India -USA

Latest News







Copyright Kalyan Krishna MediaZ Private Limited. All rights reserved. Unless otherwise indicated, all materials on these pages are copyrighted by Kalyan Krishna MediaZ Private Limited. All rights reserved. No part of these pages, either text or image may be used for any purpose. By continuing past this page, you agree to our Terms of Service, Cookie Policy, Privacy Policy and Content Policies.